CompuGroup Medical SE & Co. KGaA | WebDisclosure

Basculer en Français

8642	Companies
145460	Keywords
81173	Articles
77862	Press releases

Headlines Articles Press releases CompuGroup Medical SE & Co. KGaA

Home
Companies
CompuGroup Medical SE & Co. KGaA

BRIEF

published on 04/30/2025 at 07:44, 5 days 2 hours ago

CompuGroup Medical connaît un démarrage lent jusqu'en 2025

Marge D'EBITDA Investissement En R&D E-santé T1 2025 Croissance Récurrente
BRIEF

published on 04/30/2025 at 07:44, 5 days 2 hours ago

CompuGroup Medical Experiences Slow Start to 2025

EBITDA Margin R&D Investment E-health Q1 2025 Recurrence Growth
PRESS RELEASE

published on 04/30/2025 at 07:39, 5 days 2 hours ago

Q1/2025: CompuGroup Medical reports slow start into the year
CompuGroup Medical reports 1% revenue increase in Q1/2025. Adjusted EBITDA declined by 16%, but recurring revenues grew by 2%

Revenue Increase CompuGroup Medical Recurring Revenues EBITDA Decline Q1/2025
BRIEF

published on 04/17/2025 at 13:44, 17 days 20 hours ago

CompuGroup Medical finalise son partenariat stratégique avec CVC

Offre Publique D'achat CompuGroup Medical CVC Capital Partners Structure De L'actionnariat Innovation Dans Le Domaine Des Soins De Santé
BRIEF

published on 04/17/2025 at 13:44, 17 days 20 hours ago

CompuGroup Medical Finalizes Strategic Partnership with CVC

Shareholder Structure CompuGroup Medical Healthcare Innovation Takeover Offer CVC Capital Partners
PRESS RELEASE

published on 04/17/2025 at 13:39, 17 days 20 hours ago

Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
Final regulatory approval granted for CompuGroup Medical's voluntary public takeover offer, establishing strategic partnership with CVC upon completion. Offer conditions fulfilled

Strategic Partnership CompuGroup Medical Regulatory Approval Takeover Offer CVC
BRIEF

published on 03/06/2025 at 07:47, 1 month 30 days ago

CompuGroup Medical's 2024 Financials Align with Revised Guidance

Revenue Decline CompuGroup Medical Growth Forecast 2024 Financial Results AI Investment
BRIEF

published on 03/06/2025 at 07:47, 1 month 30 days ago

Les résultats financiers 2024 de CompuGroup Medical sont conformes aux prévisions révisées

CompuGroup Medical Baisse Des Revenus Prévisions De Croissance Résultats Financiers 2024 Investissement En IA
PRESS RELEASE

published on 03/06/2025 at 07:42, 1 month 30 days ago

CGM reports FY 2024 financials in line with revised guidance and expects to return to growth path in 2025
CGM reports FY 2024 financials in line with revised guidance, with recurring revenues accounting for 74% of total revenues. Company investing in AI and expects growth in 2025

Financial Results AI CompuGroup Medical Growth Recurring Revenues
BRIEF

published on 03/04/2025 at 13:48, 2 months ago

CompuGroup Medical Plans Minimum Dividend Payout for 2024

Revenue Decline CompuGroup Medical Dividend Reduction 2024 Financial Year AI Investment

Accesswire

Published on 05/05/2025 at 09:05, 1 hour 1 minute ago

BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
Published on 05/05/2025 at 08:00, 2 hours 6 minutes ago

Formation Metals Unlocks Copper-Zinc Potential at the N2 Gold Deposit with Insights from Revaluation of Historic Drill Core
Published on 05/05/2025 at 02:30, 7 hours 36 minutes ago

Optimised Scoping Study Accelerates Tunkillia PFS Programs
Published on 05/03/2025 at 03:40, 2 days 6 hours ago

Snipp Interactive Announces Delay in Filing Audited Fiscal 2024 Financial Statements
Published on 05/03/2025 at 03:00, 2 days 7 hours ago

Vision Marine Technologies Inc. Announces Postponement of Annual Meeting of Shareholders

View all ACCESSWIRE

EQS Group

Published on 05/05/2025 at 09:40, 26 minutes ago

Ministry of Foreign and European Affairs Showcases Decent Cybersecurity at Innovation Day on Cybersecurity
Published on 05/05/2025 at 09:15, 51 minutes ago

Accelleron focuses on growth in injection systems and invests in Italy
Published on 05/05/2025 at 08:35, 1 hour 31 minutes ago

Eurobattery Minerals passed the first phase of evaluation in European Funding Call
Published on 05/05/2025 at 08:02, 2 hours 4 minutes ago

PFISTERER Holding SE announces price range and offers structure for planned IPO
Published on 05/05/2025 at 08:00, 2 hours 6 minutes ago

Aquis Stock Exchange: withdrawal of trading

Les Echos

Published on 05/05/2025 at 09:59, 7 minutes ago

Mersen: Number of shares and voting rights as of April 30, 2025
Published on 05/05/2025 at 09:59, 7 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 avril 2025
Published on 05/05/2025 at 08:30, 1 hour 36 minutes ago

NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA permettant de mieux décrire l’effet de NFL-101, son traitement first in class contre l’addiction au tabac, mettant notamment en évidence son activité prolongée
Published on 05/05/2025 at 08:30, 1 hour 36 minutes ago

NFL Biosciences announces results from a new study conducted with the CEA providing further insight into the effects of NFL-101, its first-in-class treatment for tobacco addiction, and highlighting its prolonged activity
Published on 05/05/2025 at 07:30, 2 hours 36 minutes ago

Gimv geht Partnerschaft mit Ambulantis ein und unterstützt die Wachstumsambitionen des Unternehmens

View all LES ECHOS COMFI WIRE